In the realm of diabetes management, the assessment of blood glucose control has long relied on the measurement of Hemoglobin A1c (HbA1c), which provides an average of blood glucose levels over several months. This standard metric has been instrumental in guiding treatment decisions for individuals with diabetes. However, as medical technology advances, we are now witnessing a paradigm shift in how we evaluate and manage diabetes. Dr. M Khalid Munir, Ex-Consultant, Khamenei Wockhardt Hospital in Hyderabad, highlights the game-changing developments in the field of diabetes control assessment. He emphasizes that while HbA1c remains a vital tool, it is no longer the sole determinant of diabetes management. The advent of Continuous Glucose Monitoring (CGM) systems has ushered in a new era, offering a wealth of additional metrics that can provide a more comprehensive understanding of a patient's glucose control. One of the most significant advancements enabled by CGM systems is the int...